What is the annual incidence of epiretinal membrane in adults, especially in patients over 60 years old or those with diabetes mellitus or hypercholesterolemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence Rate of Epiretinal Membrane

The annual incidence rate of epiretinal membrane is approximately 9.4 per 100 eye-years, translating to a 5-year cumulative incidence of 37.6% in elderly populations when detected using spectral-domain OCT. 1

Annual Incidence Data

The most robust incidence data comes from longitudinal studies using modern imaging:

  • In French elderly subjects (mean follow-up 5.09 years): The incidence rate was 9.42 per 100 eye-years (95% CI: 7.36-12.05), corresponding to a 5-year cumulative incidence of 37.6%. 1 This represents the highest quality incidence data available, as it utilized spectral-domain OCT for detection rather than fundus photography alone.

  • In Korean adults aged 50+ years: The 5-year age-standardized incidence was 3.8% (95% CI: 2.8-4.8), including 2.3% with cellophane macular reflex and 1.5% with preretinal macular fibrosis. 2 This lower rate likely reflects the use of fundus photography rather than OCT.

Age-Specific Considerations

Increasing age is the most consistently identified risk factor across all studies. 3

  • The incidence increases progressively with age, though one recent study in English patients over 65 found no additional age-related increase within this elderly cohort. 4
  • Peak incidence occurs in the 7th and 8th decades of life. 3

High-Risk Populations

Patients with Diabetes Mellitus

Diabetes and hypercholesterolemia are associated with higher rates of cellophane maculopathy (early ERM). 3

  • Diabetic patients without retinopathy show a 3.2-fold increased risk of preretinal macular fibrosis (odds ratio 3.2; 95% CI: 1.4-7.2). 5
  • However, one recent study found no significant correlation between diabetes and idiopathic ERM in elderly patients. 4

Patients with Hypercholesterolemia

  • Hypercholesterolemia is associated with higher rates of cellophane maculopathy. 3
  • Hypertriglyceridemia (≥250 mg/dL) increases risk with an adjusted odds ratio of 3.16 (95% CI: 1.54-6.49). 2

Critical Factors Affecting Incidence Detection

The detection method dramatically impacts reported incidence rates:

  • Spectral-domain OCT detects significantly higher rates than fundus photography alone, explaining why the French ALIENOR study found much higher incidence (9.42 per 100 eye-years) compared to earlier photography-based studies. 1
  • Studies using OCT in elderly populations document prevalence as high as 34.1%, compared to 2.2-28.9% with fundus photography. 3

Additional Risk Factors for Incident ERM

Beyond age, diabetes, and hypercholesterolemia, the following factors predict new ERM development:

  • Vitreomacular or vitreopapillary adhesion at baseline (hazard ratio 2.15; P=0.02) 1
  • Choroidal thinning (hazard ratio 1.04 per 10 μm decrease; P=0.02) 1
  • ERM in the contralateral eye (P=0.02) 1
  • Smoking after age 85 (hazard ratio 6.01; P=0.003) 1

Important Clinical Caveats

Most incident ERMs are idiopathic (90.7%), with only 9.3% being secondary (predominantly post-cataract surgery at 43.5% of secondary cases). 4

The 5-year progression rate from early to advanced ERM is relatively low at 6.9%, suggesting that most ERMs remain stable once formed. 1

Bilateral involvement occurs in 20-35% of cases, necessitating examination of both eyes when ERM is detected. 3

The wide variation in reported incidence (3.8% to 37.6% over 5 years) reflects differences in detection methods, population characteristics, and classification systems rather than true geographic variation. 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.